Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medrol for Post-Operative Pain in AIS
NCT06453083Phase 1Completed
- Sponsor
- University of Utah
- Start
- Jan 2023
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postoperative pain comparing Medrol with Placebo (2 arms). Primary endpoint: Visual Analog Scale (VAS) pain at Day 1. Started Jan 2023; status: completed.
02
Drugs
methylprednisolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06453083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06453083.